Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guérin for High-risk Non-muscle-invasive Bladder Cancer During the COVID-19 Pandemic.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32349928.
- Also identified by DOI 10.1016/j.eururo.2020.04.039 and PMC identifier 7180366.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Non-muscle-invasive bladder cancer patients with COVID-19 are more likely to develop acute respiratory distress syndrome. Thus, several adjustments to the use of intravesical instillations of bacillus Calmette-Guérin should be made during the current pandemic to limit the risk of contamination.
Medical subject headings
- BCG Vaccine
- Betacoronavirus
- Coronavirus Infections
- Pandemics
- Pneumonia, Viral
- Urinary Bladder Neoplasms